Sitokrom P450 Enzimleri: Biyokimyasal Temellerden Modern Tıptaki Uygulamalara

Stavropoulou E, Pircalabioru GG, Bezirtzoglou E. The Role of Cytochromes P450 in Infection. Front Immunol. 2018;9:89.

Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet. 2002;360(9340):1155–62.

Zahoor I, Rui B, Khan J, Datta I, Giri S. An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview. Cell Mol Life Sci. 2021;78(7):3181–3203.

McDonnell AM, Dang CH. Basic review of the cytochrome P450 system. J Adv Pract Oncol. 2013;4(4):263–8.

Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352:2211–21.

Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother. 1995;29:619–24.

Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286:2270–9.

Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans, and their descendants. Pharmacogenomics. 2002;3:229–43.

Special report: genotyping for cytochrome P450 polymorphisms to determine drug-metabolizer status. Technol Eval Cent Asses Program Exec Summ. 2004;19:1–2.

Abraham BK, Adithan C. Genetic polymorphism of CYP2D6. Indian J Pharmacol. 2001;33:147–69.

Bernard S, Neville KA, Nguyen AT, Flockhart DA. Inter-ethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist. 2006;11:126–35.

Chong E, Ensom MH. Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy. 2003;23:460–71.

Weinshilboum R. Inheritance and drug response. N Engl J Med. 2003;348:529–37.

Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103–41.

Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol. 2008;21(1):70–83.

Jimenez-Lopez JM, Cederbaum AI. CYP2E1-dependent oxidative stress and toxicity: Role in ethanol-induced liver injury. Expert Opin Drug Metab Toxicol. 2005;1(4):671–85.

Zangar RC, Davydov DR, Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol. 2004;199(3):316–31.

Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol. 2008;21(1):70–83.

Rendic S, Guengerich FP. Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol. 2012;25(7):1316–83.

Zack M, Stupichev DN, Moore AJ, Slobodchikov ID, Sokolov DG, Trifonov IF, et al. Artificial Intelligence and Multi-Omics in Pharmacogenomics: A New Era of Precision Medicine. Mayo Clin Proc Digit Health. 2025;3(3):100246.

Taherdoost H, Ghofrani A. AI's role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy. Intell Pharm. 2024;2(5):643–50.

Farmaki A, Manolopoulos E, Natsiavas P. Will Precision Medicine Meet Digital Health? A systematic review of pharmacogenomics clinical decision support systems used in clinical practice. OMICS. 2024;28(9):442–60.

Shaman JA. The Future of Pharmacogenomics: Integrating Epigenetics, Nutrigenomics, and Beyond. J Pers Med. 2024;14(12):1121.

Son A, Park J, Kim W, et al. Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy. Toxics. 2024;12(11):822.